HOME >> BIOLOGY >> NEWS
Could Humpback Whales Be Singing Grammatically?

THE songs of the humpback whale are more complex than anyone realised. So claim scientists in Massachusetts who are analysing the "grammar" of whale calls with information theory. They hope this approach will tell them more about the purpose of the animals' clicks and squeals.

Information theory was born in the late 1940s, thanks to an influential series of papers by Claude Shannon of Bell Laboratories in New Jersey. Shannon described a way to measure the amount of information in a stream of symbols via the stream's "entropy" or unpredictability. The symbols could be anything from binary code to letters in words. Crucially, the less predictable the stream of symbols, the more information it is likely to contain-just as the repetitive sequence "eat eat eat" conveys less information than the non-repetitive sequence "eat this pie".

The same tools can be applied to whale calls. "The humpback whale song slowly changes over the season," explains John Buck of the University of Massachusetts at Dartmouth. "They have different themes that are repeated in a regular order-some die off, some are modified, and some are added."

These themes are made up of predictable sequences of sounds, or phrases. Buck and his colleagues took recordings of humpback whales and measured variations in the songs, such as changes in frequency. They then turned these measurements into a sequence of symbols representing the different themes and measured the entropy of the sequences.

At a joint meeting of European and American acoustical societies in Berlin next month, Buck's student Ryuji Suzuki will announce the preliminary findings. Buck says the entropy of the whales' calls hints that they may have a hierarchical grammar, in which one sound is varied to agree with a sound quite far back in a sequence. This is the same as human languages, where a word at the end of a sentence can be grammatically linked to the first word.

"I'm intrigued,
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-171-331-2751
New Scientist
24-Feb-1999


Page: 1 2

Related biology news :

1. Endometriosis: Could angiostatic therapy be the new treatment of the future?
2. Could mice hold the secret to longer life?
3. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
4. Could memory performance and spatial learning be genetically based?
5. Could a specific protein contribute to erectile dysfunction for the diabetic and obese?
6. Could diabetes treatments fight cancer?
7. Could rice be the source for a natural herbicide?
8. Could hibernators hold the key to improving organ preservation?
9. Could Bt transgenic crops have nutritionally favourable effects on insects?
10. Could one less cookie a day help the fight against fat?
11. Could an anti-marijuana compound hold the key to body weight and appetite control?

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Could Humpback Whales Singing Grammatically

(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... and BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... in Europe and the United States and plenary talks ... planned for SPIE Optics + Optoelectronics next ... over 700 technical presentations in 17 conferences alongside a ... for optics and photonics , the event will run ...
(Date:3/30/2015)... 30, 2015  Naldemedine, an investigational peripherally acting ... & Co., Ltd., met its primary and secondary ... for the treatment of opioid-induced constipation (OIC) in ... therapy. Study results showed that naldemedine (0.2 mg ... frequency of spontaneous bowel movement (SBM) compared with ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: